Registry of mitral stenosis patients treated with percutaneous mitral balloon commissurotomy
Official title: Prospective Multicenter Registry of Patients With Mitral Stenosis Undergoing Percutaneous Mitral Balloon Commissurotomy
Run by Asan Medical Center · NCT07175532 · Data updated 2026-11-12
See how people with mitral stenosis do after percutaneous mitral balloon commissurotomy (PMBC) and which method best determines the Inoue balloon size.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 89 Years |
| Sex | All |
| Enrollment | 400 (estimated) |
| Sponsor | Asan Medical Center Academic / other |
| Locations | 1 site (Seoul) |
| Status | Recruiting |
| Started | May 1, 2025 |
| Main results expected | December 31, 2031 |
| Study ends | December 31, 2031 |
| Registry record updated | September 16, 2025 |
| Trial ID | NCT07175532 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults with mitral stenosis who are scheduled for PMBC, can give informed consent, and do not have severe comorbidities that limit life expectancy to under one year.
✕Probably not a fit
Patients who cannot provide informed consent, have serious comorbid conditions limiting life expectancy, or have non-cardiac limitations (NYHA III–IV) are unlikely to gain benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a prospective, multicenter registry enrolling patients with mitral stenosis who undergo PMBC at tertiary referral hospitals in Korea. Investigators will collect baseline clinical data, procedural details, and follow-up outcomes to characterize short- and long-term results after PMBC. The registry will compare methods used to choose the Inoue balloon size and correlate sizing approaches with clinical and echocardiographic outcomes. Participation is observational and does not change clinical care beyond standard procedures and follow-up.
Why it matters
Potential benefit: If successful, the registry could help clinicians choose the best balloon sizing method and improve outcomes after PMBC.
How similar studies have gone: PMBC outcomes and balloon sizing have been reported in prior single-center and registry reports, so the general approach is established though this multicenter Korean prospective registry aims to add broader, country-level data.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with mitral stenosis undergoing PMBC Exclusion Criteria: * Patients who cannot understand this study due to mental illness * Serious comorbidity limiting life expectancy within 1 year * Limited activity (NYHA class III or IV) due to non-cardiac disease
Where it's running
-
Asan Medical Center
Seoul, South Korea Recruiting
Study contacts
- Study coordinator: Jong-Min Song
- Email: jmsong@amc.seoul.kr
- Phone: 82230103168
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Exercise capacity, muscle oxygenation, and aortic stiffness after mitral valve intervention
This project will test whether adults who had a mitral valve intervention have lower exercise capacity, altered muscle oxygen levels, and stiffer aortas compared with healthy adults.
-
Surgical implantation of a polymer prosthetic mitral or aortic valve
This will test a surgically implanted polymer heart valve to see if it is safe and works well for adults who need mitral or aortic valve replacement.
-
Abbott Cephea registry for mitral valve disease
Collects clinical information on adults with symptomatic mitral valve disease to see how correcting the valve with the Cephea system affects outcomes for patients who might be candidates for transcatheter mitral valve replacement.
-
Using lung ultrasound to improve outcomes in cardiac surgery patients
This study is testing if using lung ultrasound can help doctors find lung problems earlier in patients after heart surgery compared to regular X-rays and CT scans.
-
MITRAL II Pivotal: Transcatheter mitral valve replacement for severe mitral annular calcification
This trial tests whether placing an Edwards SAPIEN transcatheter valve through a transseptal approach helps high-surgical-risk adults with severe mitral annular calcification and symptomatic mitral valve dysfunction.
-
Tracking progression and consequences of heart valve disease
This project will follow adults with moderate or worse valve disease to see if clinical tests and imaging can predict when their condition will get worse.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.